It could have remained empty for years. Instead, the former pharmaceutical research campus has found new life as a thriving hub of innovation.
Accountable care organizations seek to improve the care received by traditional Medicare patients while holding cost growth down, but a new study raises questions about its success.
A collaborative U-M team shows that liver injury is less likely to originate from popular cancer immunotherapy drug, pembrolizumab, than tumor progression.
FDA links rare cancer to textured breast implants and urges women to monitor themselves for possible symptoms.
A new Michigan Medicine study found that implementing a dedicated emergency medicine department-based intensive care unit improved patient survival rates and lowered inpatient intensive care unit (ICU) admissions.
Injuries are a leading cause of death — and completely preventable.